Lyme (and other blood) Tests

Caution: This information was collected by scanning and then editing a rather poor fax. Any information which appears silly or dangerous should be checked against the original FAX or source document. MF

Back to Medical.htm

%SBLYMER*     IF
LYME AB SCREEN 1.64 H EIA VALUE  
***EXPLANATION OF EIA VALUE    
<1.00 NEGATIVE    
1.00-1.19 EQUIVOCAL    
> OR = 1.20 POSITIVE    
DUE TO RECOMENDATIONS BY THE FOOD AND DRUG
ADMINISTRATION (FDA), ALL POSITIVE OR EQUIVOCAL
BORRELIA BURGDORFERI ANTIBODY ElA (SCREENING)
TESTS WILL BE FOLLOWED BY THE WESTERN BLOT.
THE SCREENING TEST FOR B. BURGDORFERI HAS A LOW
PREDICTIVE VALUE FOR A NEGATIVE RESULT WHEN USED TO
DETECT EARLY INFECTION AND A LOW PREDICTIVE VALUE OF
A POSITIVE RESULT WHEN EXPOSURE HISTORY, SYMPTOMS,
AND CLINICAL. FINDINGS ARE NOT CONSISTENT WITH LYME
DISEASE. POSTIVE OR EQUIVOCAL RESULTS SHOULD NOT BE
INTERPRETED AS TRUE POSITIVES UNTIL A SECOND-STEP
TESTING OF THE SPECIMEN IS DONE USING A METHOD THAT
IS MORE SPECIFIC FOR ANTIBODIES TO B. BURGDORFERI
(E.G. WESTERN BLOT)
VERIFIED BY REPEAT ANALYSIS

----------------

8593RSL= *    
IGG POSITIVE NEGATIVE
BANDS PRESENT 18, 28, 39, 41, 45,. 58KD  
***EXPLANATION OF TEST RESULTS ***    
THE IGG WB TEST IS CONSIDERED POSITIVE IF ANY FIVE OF THE FOLLOWING TEN BANDS ARE PRESENT; 18, OSP C (21/23). 28, 30,. 39, 41, 45, 59, 66, OR 93 (83).    
IGM NEGATIVE NEGATIVE
BANDS PRESENT 23KD  
***EXPLANATION OF TEST RESULTS***    
THE ABOVE LISTED BANDS WERE DETECTED BUT DO NOT MEET THE FOLLOWING    
CRITERIA FOR A POSITIVE IGM WB: THE IGM WB IS CONSIDERED POSITIVE    
IF TWO OF THE FOLLOWING THREE BANDS ARE PRESENT: OSP C (21/23), 39    
OR 41, KD. A NEGATIVE IGM WB DOES NOT RULE OUT LYME DISEASE.    
SPECIMENS DRAWN TOO SOON AFTER ONSET OF DISEASE (ESPECIALLY IF THE    
PATIENT IS TREATED EARLY) MAY NOT HAVE DEVELOPED A SUFFICIENT    
ANTIBODY RESPONSE TO BE CONSIDERED POSITIVE. IF CLINICALLY INDICATED,    
PLEASE RESUBMIT AN ADDITIONAL SPECIMEN IN TWO TO FOUR WEEKS    

>>- REPORT CONTINUED ON NEXT PAGE <<<

[MORE EDITING REQUIRED]

PID PANEL 3.25 - MG/PT-a
TRIGLYCERIDES      
CHOLESTEROL, 7 TAL   59$ S MG/IL
HDL-CROLESTflO 47   MG/DL

----------------

%SS41SB  
LDL-CRQLESTE OL 2~33 K

----------------

NATIONAL CHOLESTEROL EDUCATION PROQRAM (Na?)
TREATMENT GUIDELINES SUMMARY

----------------

DIETARY THERAPY DRUG TRfl~#t GOAL OF      
INITIATION LEVEL CONS IDKRAflQW flERAPY  
LDL dOLES OL (KQ/DL) (MG/DL) (WI/DL)  
~        
W/OCED <2 ~0R-16O ~OR.l9# clip
RISK FACTO        
W/OCRD <OR=130 >OR =160 ~l30  
OR - 2        
RISK FACTO        
WITRCHD ~100 ~ORs 130 <OkinlOO  
NCEP RICO S THAT DIETARY an/OR DRUG ThSUt NOT BE    
INITIATED ED ON A SINGLE LDL CHOLISTEUGIa ~mrur. PLEASE    
REFER TO S COND REPORT OF THE NCEP IN JAfl LflS,fl9~30l5-23        
FOR GTJIDEL S.        
    c200    
    <200    
    MG/DL (CALC) 0-131    
  4.36 (CALC) ~ <4.98

----------------[EDITED]

COMP METAB PANEL W/O CO2, ALT
GLUCOSE   96 MG/DL 70-125
UREA NITROGEN (BUN)   17 MG/DL 7-25
CREATINIME   1.3 MG/DL 0.5-1.4
BUN/CREATINE RATIO   13 (CALC) 6-25
SODIUM   141 MEQ/L 135-146
POTASSIUM   4.7 MEQ/L 3.5-5.3
CHLORIDE   107 MEQ/L 95-109
CALCIUM   8.9 MEQ/L 9.5-3-0 .3
PROTEIN, TOT   6.8 G/DL 6.0-8.5
ALBUMIN   3.9 G/DL 3.2-5.0
GLOBULIN   2.9 G/DL (CALC) 24-4.2
ALDUMIK/GLOB 114 PATIO 1.3 (CALC) 0.8-2.0
BILIRUBIN, AL 0.9 MG/DL 0.0-1.3
ALKALflIE PROS HATASE 98 U/L 20-125
AWL' (SOOT)   34 U/L 0-42

----------------[MORE EDITING REQUIRED]

SED RATE BY MODIED WESTERGREN      
WESTERGREN

4

MM/HR < OR =20
EU SPEC ARE STABLE FOR 4-6 HOURS AT ROOM    
TEMPERATURE (12 HOURS I? REFRIGERATED). urn *mxtrs    
TREIW LOWER ITS INCREASED SPECIMEN AGE. ~WSZZ1ZR    
USE OF C- IV! PROTEIN TO ASSESS ACUTW #i&M    
RESPONSES.      
CBC (INCLUDES DIFF/PLT)      
WHITE BLOOD CELL COUNT 6.1 THOUS/MCL 3.8-10.8
RED BLOOD CELL COUNT 4.72 MILL/MCL 4.40-5.30
HEMOGLOBIN 144 G/DL 13.8-17.2
HEMATOCRIT 41.4 % 41.0-50.0
MCV 876 FL 80.0-100.0
MCH 30.6 PG 27.0-33.0
MCHC 34.9 G/DL 32.0-36.0
RDW 14.7 % 9.0-15.0
PLATELET COUNT 195 THOUS/MCL 130-400
ABSOLUTE NEUTROPHILS 4221 CELLS/MCL 1500-7800
NEUTROPHILS 69.2 %  
ABSOLUTE LYMPHOCYTES 1183 CELLS/MCL 850-4100
LYMPHOCYTES 19.4 %  
ABSOLUTE MONOCYTES 506 CELLS/MCL 200-1100
MONOCYTES 3.3 %  
ABSOLUTE EOSINOPHILS 165 CELLS/MCL 50-550
EOSINOPHILS 2.7 %  
ABSOLUTE BASOPHILS 24 CELLS/MCL 0-200
BASOPHILS 0 0.4 0%

----------------

HIV-1 AB SCREEN    
HIV- AB SCREEN W/REFL NON-REACTIVE NON-REACTIVE
***NOTE: A NON REACTIVE RESULT INDICATES.THAT HIV1 (HVLT-III)
ANTIBODIES HAVE NOT BEEN FOUND IN THIS PATIENT SPECIMEN.
A NON-REACTIVE RESULT, HOWEVER. DOES NOT PRECLUDE
PREVIOUS EXPOSURE OR INFECTION WITH HTV1.

----------------[MORE EDITING REQUIRED]

IUIMUNOYIXATION  
"IV    
RIV- AD BCE! N/RIFt, NON-REWTCVR NON-REACTIVE

----------------

***NOTE: A K-REACTIVE RESULT INDICATES TE~T UZV1 (HTLV-III)  
IBODh1S HAVE NQT RINK 1OU~ ~)I ~S~Z~S ~`ATI1MT SPECIMEN.  
A N- RKAC'rIVE RESULT, HOWEVER. ~OU~ ~ PRECLUDE  
P OUS EXPOSURE OR INFECTION wrri KI~n.

----------------